高级检索
当前位置: 首页 > 详情页

Cucurbitacin E inhibits the Yes-associated protein signaling pathway and suppresses brain metastasis of human non-small cell lung cancer in a murine model

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco,San Francisco, CA 94115, USA [2]Department of Thoracic Medicine, Chang Gung Memorial Hospital Linkou Branch,Taoyuan 33305 [3]School of Medicine, Chang Gung University, Taoyuan 33302, Taiwan, R.O.C. [4]Department of Thoracic Surgery, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine,University of Electronic Science and Technology of China, Chengdu, Sichuan 610041, P.R. China [5]Department of Pathology, University of California, San Francisco, San Francisco, CA 94115, USA
出处:
ISSN:

关键词: cucurbitacin E brain metastasis non-small cell lung cancer Yes-associated protein Hippo signaling

摘要:
Human non-small cell lung cancer (NSCLC) is associated with an extremely poor prognosis especially for the 40% of patients who develop brain metastasis, and few treatment strategies exist. Cucurbitacin E (CuE), an oxygenated tetracyclic triterpenoid isolated from plants particularly of the family Cucurbitaceae, has shown anti-tumorigenic properties in several types of cancer, yet the mechanism remains unclear. Yes-associated protein (YAP), a main mediator of the Hippo signaling pathway, promotes tumorigenesis, drug resistance and metastasis in human NSCLC. The present study was designed to ascertain whether CuE inhibits YAP and its downstream gene expression in the human NSCLC cell lines H2030-BrM3 (K-ras(G12C) mutation) and PC9-BrM3 (EGFR(Delta exon19) mutation), which have high potential for brain metastasis. The efficacy of CuE in suppressing brain metastasis of H2030-BrM3 cells in a murine model was also investigated. It was found that after CuE treatment in H2030-BrM3 and PC9-BrM3 cells, YAP protein expression was decreased, and YAP signaling GTIIC reporter activity and expression of the downstream genes CTGF and CYR61 were significantly (P<0.01) decreased. CuE treatment also reduced the migration and invasion abilities of the H2030-BrM3 and PC9-BrM3 cells. Finally, our in vivo study showed that CuE treatment (0.2 mg/kg) suppressed H2030-BrM3 cell brain metastasis and that mice treated with CuE survived longer than the control mice treated with 10% DMSO (P=0.02). The present study is the first to demonstrate that CuE treatment inhibits YAP and the signaling downstream gene expression in human NSCLC in vitro, and suppresses brain metastasis of NSCLC in a murine model. More studies to verify the promising efficacy of CuE in inhibiting brain metastasis of NSCLC and various other cancers may be warranted.

基金:

基金编号: R01 CA140654 CMRPG3G1661 CMRPG5H0141

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
最新[2023]版:
大类 | 3 区 医学
小类 | 4 区 肿瘤学
JCR分区:
出版当年[2019]版:
Q2 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2019版] 出版当年五年平均 出版前一年[2018版] 出版后一年[2020版]

第一作者:
第一作者机构: [1]Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco,San Francisco, CA 94115, USA [2]Department of Thoracic Medicine, Chang Gung Memorial Hospital Linkou Branch,Taoyuan 33305 [3]School of Medicine, Chang Gung University, Taoyuan 33302, Taiwan, R.O.C.
通讯作者:
通讯机构: [1]Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco,San Francisco, CA 94115, USA [*1]Department of Surgery, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 2340 Sutter Street, N‑221, San Francisco, CA 94115, USA
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43377 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号